ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP)

44.40
-0.11
(-0.25%)
Al cierre: 26 Febrero 3:00PM
44.70
0.30
( 0.68% )
Fuera de horario: 5:24PM

Calls

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
39.504.505.804.205.150.000.00 %02-
40.003.804.704.804.250.000.00 %070-
40.503.205.200.004.200.000.00 %00-
41.003.403.903.743.650.000.00 %0112-
41.502.603.707.803.150.000.00 %05-
42.002.502.753.702.6250.8027.59 %108211:34:09
42.502.052.309.742.1750.000.00 %09-
43.001.601.851.881.7250.095.03 %8020613:05:24
43.501.301.502.601.400.000.00 %0132-
44.001.001.201.701.100.4333.86 %115812:21:21
44.500.750.950.600.85-0.50-45.45 %131614:35:49
45.000.600.700.650.65-0.35-35.00 %10725914:56:29
45.500.400.800.800.600.2340.35 %44711:57:29
46.000.300.450.380.375-0.22-36.67 %10614514:52:56
46.500.200.400.400.300.000.00 %173012:38:19
47.000.150.300.250.225-0.10-28.57 %9016214:03:27
47.500.100.300.300.200.027.14 %183314:52:08
48.000.100.250.100.175-0.13-56.52 %7814014:59:06
48.500.050.200.200.1250.0211.11 %183711:18:28
49.000.050.200.080.125-0.07-46.67 %289413:03:00

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Puts

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
39.500.200.050.200.1250.000.00 %05-
40.000.090.050.090.070.000.00 %099-
40.500.000.750.000.000.000.00 %00-
41.000.360.100.360.230.000.00 %034-
41.500.050.150.050.10-0.10-66.67 %62411:38:33
42.000.100.200.180.15-0.01-5.26 %136014:41:15
42.500.150.250.240.20-0.16-40.00 %3814:51:08
43.000.250.400.430.3250.000.00 %0197-
43.500.400.500.130.45-0.40-75.47 %12411:36:42
44.000.400.650.600.525-0.15-20.00 %14848414:55:00
44.500.800.951.080.8750.088.00 %173214:35:49
45.001.101.251.501.1750.128.70 %320914:36:04
45.501.451.651.551.550.000.00 %027-
46.001.852.001.001.925-0.40-28.57 %631611:13:45
46.502.252.501.202.375-0.94-43.93 %15711:20:48
47.002.602.902.052.75-0.52-20.23 %653312:07:51
47.503.103.401.403.250.000.00 %0108-
48.003.503.803.373.65-0.39-10.37 %326513:22:04
48.503.904.503.304.200.000.00 %029-
49.004.404.803.314.60-0.94-22.12 %216810:37:18

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ULYUrgent ly Inc
US$ 0.8301
(97.64%)
6.18M
CPOPPop Culture Group Company Ltd
US$ 1.33
(92.20%)
9.26M
BLMZBloomZ Inc
US$ 0.49
(36.19%)
6.85M
NIXXNixxy Inc
US$ 2.11
(33.54%)
7.87M
ROOTRoot Inc
US$ 116.00
(17.52%)
114.53k
DMRCDigimarc Corporation
US$ 20.00
(-26.04%)
38.97k
SYTASiyata Mobile Inc
US$ 3.18
(-23.74%)
493.31k
SPGCSacks Parente Golf Inc
US$ 0.58
(-20.78%)
1.46M
TNDMTandem Diabetes Care Inc
US$ 27.3999
(-18.43%)
309.99k
PITAHeramba Electric PLC
US$ 0.5655
(-17.86%)
1.51M
NVDANVIDIA Corporation
US$ 130.03
(-0.95%)
40.91M
CPOPPop Culture Group Company Ltd
US$ 1.33
(92.20%)
9.26M
NIXXNixxy Inc
US$ 2.11
(33.54%)
7.87M
CLEUChina Liberal Education Holdings Ltd
US$ 0.063
(-15.21%)
7.09M
BLMZBloomZ Inc
US$ 0.49
(36.19%)
6.85M

CRSP Discussion

Ver más
jondoeuk jondoeuk 5 días hace
Looks pretty bullish for Casgevy https://www.businesswire.com/news/home/20250221469479/en/bluebird-bio-Announces-Definitive-Agreement-to-be-Acquired-by-Carlyle-and-SK-Capital
👍️0
TechandBio TechandBio 1 semana hace
Added a chunk today to my stash average is now 42.00

$CRSP
👍️0
TechandBio TechandBio 1 semana hace
Nice pre market action!

Very deep pipeline with a mega partner VRTX

$CRSP
👍️0
TechandBio TechandBio 2 semanas hace
Starting to turn the corner now!

Glad I re-loaded the low 40's

$CRSP
👍️ 1
jondoeuk jondoeuk 1 mes hace
Anticipated 2025 milestones https://www.globenewswire.com/news-release/2025/01/13/3008308/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and-Anticipated-2025-Milestones.html
👍️ 1
jondoeuk jondoeuk 1 mes hace
Link to the webcast https://jpmorgan.metameetings.net/events/healthcare25/sessions/58421-crispr-therapeutics/webcast/general_signin?gpu_only=true&kiosk=true+%5Bjpmorgan.metameetings.net%5D
👍️ 1
jondoeuk jondoeuk 2 meses hace
They will present at the 43rd Annual J.P. Morgan Healthcare Conference (Jan 14, at 2:15 PM PST).
👍️ 1
PonkenPlonken PonkenPlonken 3 meses hace
cheap cheap
👍️ 1
jondoeuk jondoeuk 3 meses hace
The PR https://www.globenewswire.com/news-release/2024/12/09/2993974/0/en/CRISPR-Therapeutics-Presents-Data-at-the-2024-American-Society-of-Hematology-ASH-Annual-Meeting.html

Poster https://ir.crisprtx.com/static-files/12114290-21a6-4544-9cb7-de4fe2852e94
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
Neglected ugly duckling. $NTLA, $VERV & $CRBU now do trials outside of the US.... Maybe sentiment change is on the horizon -- see below

"The CBER director also apologized for “mistakes” in how the FDA handled early work for in vivo gene therapies, which “led to offshoring of some of the trials.”"
https://endpts.com/fda-vaccine-chief-peter-marks-pledges-to-stay-as-long-as-hes-welcome/#:~:text=The%20CBER%20director%20also%20apologized,%E2%80%9Cit%20is%20really%20important.%E2%80%9D

CHEAP CHEAP
SRPT and BMS announcing nice CRISPR deals with ARWR and PRME should help this too!
👍️0
jondoeuk jondoeuk 3 meses hace
CTX130 data in R/R T-cell lymphomas (peripheral T-cell lymphoma or cutaneous T-cell lymphoma) https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00508-4/abstract

The ORR was 46.2%. Of those treated at DL3 and higher, the ORR was 51.6%.
👍️ 1
PonkenPlonken PonkenPlonken 3 meses hace
so so so undervalued and misunderstood i believe...... frankly just cheap
https://x.com/RNAiAnalyst/status/1859876294487363651
👍️ 1
jondoeuk jondoeuk 3 meses hace
They now have the ability to put in eight to nine edits. So it is a single cassette that expresses the CAR, can express a cytokine and has an shRNA-like approach to knock down genes. So there's no theoretical limit as to the number of edits, but there may be marginal utility beyond a certain point.

Hopefully, they look to improve donor selection, cell selection and manufacturing, as all could increase efficacy.
👍️ 1
jondoeuk jondoeuk 4 meses hace
ASH abstract https://ash.confex.com/ash/2024/webprogram/Paper203563.html
👍️0
jondoeuk jondoeuk 4 meses hace
Q3 business update and financial results https://www.globenewswire.com/news-release/2024/11/05/2974996/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2024-Financial-Results.html
👍️0
Monksdream Monksdream 4 meses hace
CRSP 10Q 11/5
👍️0
Monksdream Monksdream 4 meses hace
CRSP under $50
👍️0
jondoeuk jondoeuk 4 meses hace
OT: In this Dr. Urnov, PhD, laid out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies https://www.liebertpub.com/doi/10.1089/crispr.2024.0082
👍️ 1
TechandBio TechandBio 5 meses hace
CRSP will climb tremendously over the years.
SMMT went from $1.00-30.00+ this year cancer drug superior to Mercks Keytruda
ICCM company being over looked that kills cancers by freezing them 97% non recurrence rate for breast cancer after 5 years and superior data to lung cancer safe cryoblation is done in less than hour.
https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html

https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html
👍️0
Monksdream Monksdream 5 meses hace
Buy range again thanks a bunch
👍️0
Monksdream Monksdream 5 meses hace
Buy range again thanks a bunch
👍️0
OldAIMGuy OldAIMGuy 5 meses hace
Hi MD,
Here's a little longer view:


This might also be a cyclical low here. But, most of 2024 has shown severe distribution of shares until about the last month. That, at least, seems to be flattening out.
Best wishes,
OAG
👍️0
Monksdream Monksdream 5 meses hace
CRSP trend since February remains bearish
👍️0
jondoeuk jondoeuk 7 meses hace
Q2 results https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200100452.html
👍️0
lambchops lambchops 7 meses hace
Hey Monk, Hopefully you bought some shares on Friday@ Sold at 10% discount!

LC

CRISPR!!!
👍️0
Monksdream Monksdream 7 meses hace
CRSP under $75
👍️0
TechandBio TechandBio 8 meses hace
Crispr added some $120 Vertical debit spreads in 2026

$CRSP
👍️ 1
axelvento axelvento 9 meses hace
I agree.....solid company$$$$$$$$
👍️0
Monksdream Monksdream 9 meses hace
It may take some time for CRSP returns to a $200 price tag
The same could be said for hundreds of other stocks that soared during Covid mania
Since then the stock has rallied from low points
With all that money the company has to do incredible things with its biotechnology the stock isn’t going to zero
👍️ 1
axelvento axelvento 10 meses hace
Strong balance sheet with approximately $2.1 billion in cash, cash equivalents, and marketable securities as of March 31, 2024

https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000059.html
👍️0
jondoeuk jondoeuk 10 meses hace
(OT): A new AI paper from Princeton and Stanford https://www.biorxiv.org/content/10.1101/2024.04.25.591003v2.full

CRISPR-GPT demonstrated a marked improvement in gene-editing experiments, increasing the accuracy of target gene modifications by up to 30% compared to conventional methods. In validation tests, it achieved a specificity rate exceeding 95%, with a significant reduction in off-targets. The system also reduced the time required to design and plan experiments by approximately 40%, streamlining the workflow for researchers.
👍️0
jondoeuk jondoeuk 10 meses hace
Business Update and Q1 Financial Results https://uk.finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000300.html
👍️0
jondoeuk jondoeuk 10 meses hace
Highlights (plus new programs utilising in vivo gene editing) https://finance.yahoo.com/news/crispr-therapeutics-highlights-asgct-oral-110000066.html
👍️0
jondoeuk jondoeuk 10 meses hace
https://www.globenewswire.com/news-release/2024/04/22/2867236/0/en/CRISPR-Therapeutics-to-Present-Oral-Presentation-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-2024-Annual-Meeting.html

EDIT is also pursuing myocilin-related glaucoma https://www.globenewswire.com/news-release/2024/04/22/2867244/0/en/Editas-Medicine-to-Present-Pre-clinical-Data-Demonstrating-Progression-of-in-vivo-Medicines-Pipeline-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting.html
👍️0
OldAIMGuy OldAIMGuy 11 meses hace
StockCharts 3 year history with 20% ZigZag reversals................



CRSP seems to be suffering from lack of 'sponsorship' in that the stock has not shown "accumulation" trend along with the price rally since last year's October Low. There's been volume, but not accumulation bias.

Best wishes,
OAG
👍️0
OldAIMGuy OldAIMGuy 11 meses hace
Hi MD,
CRSP is now down around 1/3 from its February high. The price is where I usually start to accumulate more shares.

Best wishes,
OAG
👍️0
Monksdream Monksdream 11 meses hace
CRSP over $30
👍️0
jondoeuk jondoeuk 11 meses hace
Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-american-society-120000624.html
👍️0
Monksdream Monksdream 1 año hace
CRSP new 52 week high
👍️0
Monksdream Monksdream 1 año hace
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 1 año hace
CRSP new 52 week high
👍️ 1
Monksdream Monksdream 1 año hace
CRSP new 52 week high
👍️ 1
jondoeuk jondoeuk 1 año hace
They entered into an investment agreement for the sale of ~$280 million of its shares to a select group of institutional investors in a registered direct offering, at $71.5 apiece. The financing is being led by EcoR1 Capital and SR One with participation from existing investors and a healthcare specialist investor https://finance.yahoo.com/news/crispr-therapeutics-announces-280-million-133000932.html
👍️0
jondoeuk jondoeuk 1 año hace
EU approval https://finance.yahoo.com/news/european-commission-approves-first-crispr-065900771.html
👍️ 1
Monksdream Monksdream 1 año hace
Didn’t tank like BLUE
Recovered


More analysis from Nanolyze

👍️0
Monksdream Monksdream 1 año hace
So there has been some discussion since my last post
More in this podcast
🌈 1 🍆 1
jondoeuk jondoeuk 1 año hace
Around two months ahead of expectations https://www.globenewswire.com/news-release/2024/01/16/2810298/0/en/CRISPR-Therapeutics-Announces-U-S-Food-and-Drug-Administration-FDA-Approval-of-CASGEVY-exagamglogene-autotemcel-for-the-Treatment-of-Transfusion-Dependent-Beta-Thalassemia.html
👍️ 1
jondoeuk jondoeuk 1 año hace
Strategic Priorities and 2024 Outlook https://finance.yahoo.com/news/crispr-therapeutics-highlights-strategic-priorities-120000043.html
👍️0
jondoeuk jondoeuk 1 año hace
Webcast link https://jpmorgan.metameetings.net/events/healthcare24/sessions/49607-crispr-therapeutics-inc/webcast/general_signin?gpu_only=true&kiosk=true
👍️ 1
jondoeuk jondoeuk 1 año hace
Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-42nd-annual-133000024.html
👍️0